Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Schizophrenia
2		More general conditions related to this trial
			Mental Disorders
			Schizophrenia and Disorders with Psychotic Features
3		Interventions listed in this trial
			Ondansetron
			Pill placebo
			Atypical antipsychotic drug
4		More general drug interventions related to this trial
			Anti-Anxiety Agents
			Antiemetics
			Antipruritics
			Antipsychotic Agents
			Autonomic Agents
			Central Nervous System Agents
			Central Nervous System Depressants
			Dermatologic Agents
			Gastrointestinal Agents
			Molecular Mechanisms of Pharmacological Action
			Neurotransmitter Agents
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Psychotropic Drugs
			Serotonin Agents
			Serotonin Antagonists
			Therapeutic Uses
			Tranquilizing Agents
5		Sponsors listed in this trial
			National Institute of Mental Health (NIMH)